Frequency of anticholinergic drug use in patients treated with aripiprazole once-monthly: a 2-year cohort study using European healthcare databases
Background: Extrapyramidal symptoms (EPS) in association with the long-acting, injectable, atypical antipsychotic aripiprazole once monthly (AOM) have been observed in clinical trials, but information on EPS requiring treatment with anticholinergic drugs in clinical practice is limited. Objectives:...
Gardado en:
| Principais autores: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publishing
2025-08-01
|
| Series: | Therapeutic Advances in Psychopharmacology |
| Acceso en liña: | https://doi.org/10.1177/20451253251368010 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
